Brian Loyal

Bristol Myers Squibb is scaling AI from targeted experiments to enterprise transformation through its AI Accelerator program. In this session, hear how BMS pairs business-led innovation with AWS to move AI use cases from idea into production.

Learn how to build and deploy AI agents for life science research. AI research agents speed up scientific discovery by planning research tasks, interacting with domain-specific tools and data, and generating detailed research reports.

Learn how to accelerate scientific discovery by building, orchestrating, and visualizing computer-aided drug discovery workflows using AWS HealthOmics, state-of-the-art biological foundation models, and Jupyter.

Proteins are the molecular machines of the body and the active form of many lifesaving therapeutics. Protein language models (pLMs) use generative AI methods like self-supervised learning and transformers to modify existing proteins or design new ones.